MedPath

Use of Glidesheath Slender to Reduce Radial Artery Occlusion Following 7 French Transradial Coronary Intervention

Not Applicable
Conditions
Radial Artery Occlusion
Coronary Artery Disease
Registration Number
NCT04748068
Lead Sponsor
China National Center for Cardiovascular Diseases
Brief Summary

The objective of this study is to determine the rate of early radial artery occlusion following 7-French(7-Fr) transradial coronary intervention using a new Terumo (Tokyo, Japan) Glidesheath Slender, in comparison with the currently used 7-Fr radial sheath.

Detailed Description

Based on previously reported studies the rates of radial artery occlusion using a standard 7-Fr sheath is around 12%, compared to the previous studies of the Glidesheath Slender (see reference in the citations), the rate of radial artery occlusion was reported less than 5%. To prove Slender sheaths are superior to traditional ones, the sample size was estimated according to this, the class I error (α) is set as 0.05 on both sides, and the test efficiency (β) is set as 80%, then at least 248 patients are needed in each group.

This study will be a prospective randomized, single-blinded (patient-blinded) study, comparing the rate of radial artery occlusion between the 7-Fr Glidesheath Slender (Terumo, Japan) and the standard 7-Fr radial sheath (cordis, USA) in patients undergoing complex transradial coronary intervention.

The study will enroll patients who will undergo elective complex percutaneous coronary intervention (PCI) via 7-Fr transradial approach at Fuwai Hospital National Center for Cardiovascular Diseases.

A baseline clinical vascular \& ultrasound assessment will be performed prior to the procedure to document patency of the radial artery.

Patients will be randomized in 1:1 fashion to either receive the 7-Fr Terumo Glidesheath Slender versus the currently used 7-Fr sheath.

The standard angiogram/ PCI will be performed as per usual practice. Following the PCI, clinical vascular assessment as well as an ultrasound will be performed prior to discharge.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Patients undergoing coronary PCI via 7-Fr transradial approach
  • Informed consent
  • the patency of radial artery confirmed by ultrasound
Exclusion Criteria
  • The abnormal of radial artery confirmed by ultrasound
  • Previous failed radial access.
  • Known bleeding disorder or hypercoagulable condition
  • Cardiogenic shock

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Radial artery occlusion24 hours

Evaluated clinically and by ultrasound

Secondary Outcome Measures
NameTimeMethod
The degree of pain at the puncture site24 hours

Scored on a scale of 1-10 scoring system

Vascular access site complications24 hours

Includes: bleeding or hematoma, pseudoaneurysm, artery dissection, arteriovenous fistula, compartment syndrome of the forearm

Radial artery spasm24 hours

Radial artery spasm

Procedure success24 hours

completion of the planned procedure through the initially selected radial access route

Trial Locations

Locations (1)

Fuwai Hospital National Center for Cardiovascular Diseases

🇨🇳

Beijing, Beijing, China

Fuwai Hospital National Center for Cardiovascular Diseases
🇨🇳Beijing, Beijing, China
Hao Wang, MD,PhD
Contact
+86-15701277767
wanghao_fuwai@126.com
Kefei Dou, MD,PhD
Principal Investigator
Chenggang Zhu, MD,PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.